These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

473 related items for PubMed ID: 18215393

  • 21. Foot-and-Mouth Disease Virus neutralizing antibodies production induced by pcDNA3 and Sindbis virus based plasmid encoding FMDV P1-2A3C3D in swine.
    Dory D, Rémond M, Béven V, Cariolet R, Zientara S, Jestin A.
    Antiviral Res; 2009 Jul; 83(1):45-52. PubMed ID: 19501256
    [Abstract] [Full Text] [Related]

  • 22. Evaluation of tick-borne encephalitis DNA vaccines in monkeys.
    Schmaljohn C, Custer D, VanderZanden L, Spik K, Rossi C, Bray M.
    Virology; 1999 Oct 10; 263(1):166-74. PubMed ID: 10544091
    [Abstract] [Full Text] [Related]

  • 23. Field trials of a very potent rabies DNA vaccine which induced long lasting virus neutralizing antibodies and protection in dogs in experimental conditions.
    Bahloul C, Taieb D, Diouani MF, Ahmed SB, Chtourou Y, B'chir BI, Kharmachi H, Dellagi K.
    Vaccine; 2006 Feb 20; 24(8):1063-72. PubMed ID: 16213633
    [Abstract] [Full Text] [Related]

  • 24. Effect of porcine circovirus type 2 (PCV2) vaccination on porcine reproductive and respiratory syndrome virus (PRRSV) and PCV2 coinfection.
    Opriessnig T, Madson DM, Prickett JR, Kuhar D, Lunney JK, Elsener J, Halbur PG.
    Vet Microbiol; 2008 Sep 18; 131(1-2):103-14. PubMed ID: 18430525
    [Abstract] [Full Text] [Related]

  • 25. Rabies DNA vaccination of non-human primates: post-exposure studies using gene gun methodology that accelerates induction of neutralizing antibody and enhances neutralizing antibody titers.
    Lodmell DL, Parnell MJ, Bailey JR, Ewalt LC, Hanlon CA.
    Vaccine; 2002 May 22; 20(17-18):2221-8. PubMed ID: 12009276
    [Abstract] [Full Text] [Related]

  • 26. Nanogram quantities of plasmid DNA encoding the rabies virus glycoprotein protect mice against lethal rabies virus infection.
    Ray NB, Ewalt LC, Lodmell DL.
    Vaccine; 1997 Jun 22; 15(8):892-5. PubMed ID: 9234541
    [Abstract] [Full Text] [Related]

  • 27. Evaluation of rabies virus neutralizing antibody titres induced by intramuscular inoculation of rabies DNA vaccine in mice and Bonnet monkeys (Macaca radiata).
    Biswas S, Kalanidhi AP, Ashok MS, Reddy GS, Srinivasan VA, Rangarajan PN.
    Indian J Exp Biol; 2001 Jun 22; 39(6):533-6. PubMed ID: 12562014
    [Abstract] [Full Text] [Related]

  • 28. Intradermal vaccination of pigs against FMD with 1/10 dose results in comparable vaccine efficacy as intramuscular vaccination with a full dose.
    Eblé PL, Weerdmeester K, van Hemert-Kluitenberg F, Dekker A.
    Vaccine; 2009 Feb 18; 27(8):1272-8. PubMed ID: 19114077
    [Abstract] [Full Text] [Related]

  • 29. Rabies antibody seroprotection rates among travelers in Nepal: "rabies seroprotection in travelers".
    Ranney M, Partridge R, Jay GD, Rozzoli DE, Pandey P.
    J Travel Med; 2006 Feb 18; 13(6):329-33. PubMed ID: 17107424
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Simulated post-exposure rabies vaccination with purified chick embryo cell vaccine using a modified Thai Red Cross regimen.
    Madhusudana SN, Sanjay TV, Mahendra BJ, Suja MS.
    Int J Infect Dis; 2004 May 18; 8(3):175-9. PubMed ID: 15109593
    [Abstract] [Full Text] [Related]

  • 32. Oral vaccination of dogs (Canis familiaris) with baits containing the recombinant rabies-canine adenovirus type-2 vaccine confers long-lasting immunity against rabies.
    Zhang S, Liu Y, Fooks AR, Zhang F, Hu R.
    Vaccine; 2008 Jan 17; 26(3):345-50. PubMed ID: 18083277
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Evaluation of Japanese encephalitis virus DNA vaccine candidates in rhesus monkeys [Macaca mulatta].
    Bharati K, Rani R, Vrati S.
    Vaccine; 2009 Jan 01; 27(1):10-6. PubMed ID: 18996161
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. DNA-based immunisation against rabies and rabies-related viruses: towards multivalent vaccines.
    Perrin P, Jacob Y, Desmézières E, Tordo N.
    Dev Biol (Basel); 2000 Jan 01; 104():151-7. PubMed ID: 11713814
    [Abstract] [Full Text] [Related]

  • 38. One or three intradermal injections within one week for rabies pre-exposure immunization.
    Khawplod P, Wilde H, Sriaroon C, Chomchey P, Kamolthum T, Sitprija V.
    Dev Biol (Basel); 2008 Jan 01; 131():393-401. PubMed ID: 18634501
    [Abstract] [Full Text] [Related]

  • 39. Boosting effect of purified chick embryo cell rabies vaccine using the intradermal route in persons previously immunized by the intramuscular route or vice versa.
    Sudarshan MK, Madhusudana SN, Mahendra BJ, Narayana DH, Giri MS, Muhamuda K, Ravish HS, Venkatesh GM.
    Natl Med J India; 2006 Jan 01; 19(4):192-4. PubMed ID: 17100105
    [Abstract] [Full Text] [Related]

  • 40. Research on susceptibility of cats to the oral administration of rabies vaccine SAD B 19 Tü.
    Ciuchini F, Bozzano AI, Pestalozza S, Tollis M.
    Zentralbl Veterinarmed B; 1988 Nov 01; 35(9):675-80. PubMed ID: 3206948
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 24.